articl
deal
method
indic
detect
etiolog
agent
pulmonari
infect
discuss
restrict
diagnost
test
immunocompet
adult
articl
offer
overview
topic
descript
convent
microbiolog
method
discuss
detect
method
specif
microb
emphasi
microb
import
frequent
studi
detect
etiolog
agent
pneumonia
undergon
major
shift
technolog
emphasi
past
year
basic
techniqu
avail
physician
consid
standard
diagnost
test
done
gram
stain
cultur
agar
media
use
expector
sputum
involv
method
describ
robert
koch
centuri
serolog
test
avail
mani
pathogen
mani
decad
clinician
rare
found
use
except
epidemiolog
review
mani
serolog
test
reliabl
inform
usual
becom
avail
therapeut
decis
made
modern
molecular
method
becom
avail
rel
slow
develop
adapt
pulmonari
pathogen
polymeras
chain
reaction
pcr
detect
specif
pathogen
rapid
sensit
often
fraught
technic
difficulti
use
ration
detect
microb
found
healthi
host
virus
legionella
spp
mycobacterium
tuberculosi
addit
limit
applic
modern
molecular
techniqu
mani
bacteri
pathogen
need
cultur
determin
result
sensit
test
diverg
opinion
evolv
concern
clinic
use
diagnost
test
make
topic
one
controversi
area
pulmonari
infect
paradox
studi
detect
etiolog
agent
pneumonia
well
emphas
prepenicillin
era
time
clinician
treatment
offer
exampl
studi
heffron
book
pneumococcu
robert
austrian
call
greatest
book
ever
written
singl
microb
publish
probabl
zenith
microbi
detect
occur
late
expector
sputum
studi
sophist
time
quellung
reaction
plu
mous
inocul
use
detect
streptococcu
pneumonia
serotyp
standard
practic
bullowa
report
use
transthorac
aspir
detect
etiolog
agent
rational
aggress
approach
part
relat
need
microbi
detect
serotyp
pneumonia
time
typespecif
antiserum
avail
treatment
treatment
supplant
penicillin
becam
avail
late
bacteriolog
studi
pneumonia
never
regain
qualiti
emphasi
respect
two
technolog
develop
seem
potenti
revers
steadi
declin
qualiti
interest
microbiolog
pulmonari
infect
flexibl
bronchoscop
brought
potenti
direct
sampl
infect
site
minim
patient
discomfort
expens
requir
experienc
technician
unrealist
gener
use
turn
better
expector
sputum
instrument
contamin
passag
upper
airway
subsequ
studi
shown
techniqu
valid
method
qualiti
microbiolog
quantit
cultur
done
use
bronchoalveolar
lavag
bal
protect
brush
cathet
specimen
collect
antibiot
treatment
quantit
cultur
expector
sputum
endotrach
aspir
probabl
also
work
second
technolog
advanc
use
transtrach
aspir
bypass
contamin
flora
upper
airway
obtain
uncontamin
specimen
lower
airway
multipl
studi
show
accuraci
method
patient
chronic
lower
airway
diseas
techniqu
fell
disfavor
late
result
need
experienc
technician
side
effect
procedur
possibl
inabl
bill
third
parti
current
statu
microbiolog
studi
rel
dismal
outpati
pneumonia
group
account
communityacquir
pneumonia
cap
case
rare
undergo
studi
etiolog
agent
hospit
patient
pneumonia
blood
cultur
yield
like
etiolog
agent
pneumonia
account
bacterem
pneumonia
case
addit
studi
done
gram
stain
cultur
expector
sputum
done
minor
patient
use
method
highli
variabl
qualiti
overal
low
yield
possibl
probabl
pathogen
identifi
hospit
patient
pneumonia
mani
clinic
trial
antibiot
prospect
studi
cap
microbiolog
studi
driven
protocol
comprehens
microbiolog
studi
includ
unconvent
test
pcr
urin
antigen
assay
acut
convalesc
serolog
studi
even
report
rare
identifi
like
etiolog
agent
patient
conclus
experi
mani
pulmonari
pathogen
identifi
yet
avail
microbiolog
techniqu
sensit
enough
contrast
prepenicillin
era
like
pulmonari
pathogen
identifi
case
multipl
reason
declin
microbiolog
mani
way
reflect
state
modern
medicin
practic
issu
compound
standard
microbiolog
method
includ
fact
mani
patient
expector
sputum
mani
patient
undergon
previou
antibiot
treatment
often
preclud
meaning
cultur
common
pathogen
polici
mandat
rapid
institut
treatment
may
shift
emphasi
specimen
collect
antibiot
deliveri
second
concern
gener
declin
qualiti
control
art
specimen
collect
rapid
process
often
difficult
achiev
loss
laboratori
hospit
ward
result
clinic
laboratori
improv
act
regul
outsourc
microbiolog
studi
mani
hospit
breakdown
commun
clinician
microbiologist
also
argument
medic
need
investig
argu
empir
antibiot
treatment
work
well
welldon
microbiolog
studi
difficult
perform
test
expens
detect
pathogen
permit
exclus
copathogen
may
requir
treatment
commonli
argu
microbiolog
studi
never
clearli
shown
alter
outcom
term
morbid
mortal
length
stay
cost
also
may
argu
studi
show
result
never
done
microbiolog
studi
patient
cap
evolv
techniqu
use
year
ago
longer
seem
work
well
view
laborintens
unrealist
new
technolog
molecular
method
develop
slowli
food
drug
administr
fda
approv
pcr
detect
two
pulmonari
pathogen
tuberculosi
legionella
pneumophilia
one
main
issu
confront
clinician
much
want
need
test
articl
attempt
classifi
pathogen
three
categori
clinician
need
know
clinician
would
like
know
clinician
know
follow
agent
gener
accept
compel
need
detect
requir
special
therapi
epidemiolog
intervent
sever
acut
respiratori
syndrom
sar
influenza
especi
avian
influenza
agent
bioterror
anthrax
plagu
tularemia
legionella
spp
highmort
rate
potenti
import
epidemiolog
implic
communityacquir
methicillinresist
staphylococcu
aureu
rel
rare
caus
pneumonia
mortal
rate
exceed
even
young
previous
healthi
adult
requir
treatment
antimicrobi
drug
gener
use
empir
therapi
microb
clinician
would
like
know
microb
especi
appli
hospit
patient
pneumococc
pneumonia
sensit
test
may
import
rel
highmort
rate
even
appropri
antibiot
treatment
patient
pneumococc
bacteremia
pseudomona
aeruginosa
rel
rare
pathogen
may
encount
patient
chronic
lung
diseas
great
variat
sensit
antibiot
situat
appli
coliform
enterobacteriacea
probabl
account
cap
case
rel
easi
recov
expector
sputum
macconkey
agar
neg
cultur
usual
exclud
presenc
haemophilu
influenza
second
common
bacteri
pathogen
also
common
contamin
almost
alway
treat
empir
regimen
amoxicillin
aureu
rel
rare
pulmonari
pathogen
except
patient
superinfect
influenza
clinician
virtual
opportun
identifi
case
pneumonia
caus
chlamydia
pneumonia
mycoplasma
pneumonia
test
well
standard
good
test
gener
avail
except
research
laboratori
uncontamin
specimen
need
detect
anaerob
specimen
avail
case
except
case
infrequ
complic
empyema
futur
diagnost
test
somewhat
optimist
event
past
year
emphas
need
better
diagnost
pulmonari
infect
anthrax
epidem
brought
realiti
concern
bioterror
carri
new
demand
better
detect
method
includ
diagnost
studi
patient
enigmat
pulmonari
infect
sar
epidem
associ
death
small
fraction
annual
mortal
attribut
influenza
pneumonia
devast
global
economi
brought
incred
demand
infect
control
includ
hospit
closur
quarantin
introduct
respiratori
etiquett
diseas
control
extens
temperatur
monitor
made
detect
one
highest
prioriti
threat
avian
influenza
refocus
need
detect
specif
agent
potenti
major
global
epidem
highmort
rate
among
report
case
hong
kong
vietnam
thailand
agent
mustknow
list
rare
combin
effect
refocus
attent
rel
poor
statu
detect
method
forth
etiolog
agent
cap
emphasi
pathogen
specif
experi
like
help
launch
microbiolog
centuri
respect
use
modern
molecular
techniqu
detect
agent
pneumonia
gram
stain
one
oldest
controversi
test
detect
etiolog
agent
pneumonia
controversi
concern
differ
report
accuraci
vari
wide
depend
expertis
observ
adequaci
qualiti
control
specimen
collect
even
within
boundari
result
highli
variabl
critic
support
almost
posit
substanti
evid
literatur
gener
studi
support
use
variat
result
depend
question
ask
test
three
studi
examin
use
gram
stain
detect
pneumonia
report
sensit
rang
specif
rang
sensit
detect
bacteri
pathogen
report
rang
provid
result
restrict
analysi
purul
sampl
determin
base
gross
appear
specimen
microscop
examin
determin
concentr
leukocyt
investig
emphas
use
specimen
distinguish
pneumonia
caus
pneumonia
distinguish
viral
pathogen
bacteri
pathogen
base
cellular
constitu
mononuclear
cell
predomin
former
polymorphonuclear
pmn
cell
predomin
latter
patient
cystic
fibrosi
sputum
specimen
prove
highli
valuabl
distinguish
infect
caus
p
aeruginosa
burkholderia
cepacia
aureu
h
influenza
despit
enthusiast
support
studi
investig
dislik
process
metaanalysi
variou
report
show
compar
cultur
result
sensit
gram
stain
rang
specif
rang
cultur
result
may
inadequ
comparison
howev
inher
problem
includ
qualiti
control
specimen
collect
delay
plate
erron
result
previou
antibiot
use
better
compar
use
studi
involv
patient
posit
blood
cultur
patient
transtrach
aspir
studi
show
gram
stain
highli
favor
result
sputum
purul
import
factor
accuraci
sputum
bacteriolog
earli
investig
emphas
import
specimen
collect
physician
fleck
pick
microbiologist
point
formal
analysi
cellular
constitu
sputum
sampl
microscop
analysi
oftquot
report
murray
washington
report
emphas
cellular
analysi
criterion
discard
specimen
contain
squamou
epitheli
cellslow
power
field
lpf
time
magnif
gramstain
smear
conclus
base
observ
cultur
specimen
yield
averag
four
bacteri
speci
potenti
pathogen
found
less
two
year
later
howev
one
colleagu
mayo
clinic
robert
van
scoy
express
frustrat
clinician
discard
specimen
patient
pneumonia
plead
accept
specimen
show
pmn
cellslpf
regardless
number
squamou
epitheli
cell
sec
base
reanalysi
origin
data
widespread
accept
concept
screen
specimen
also
substanti
variat
criteria
use
tabl
one
best
studi
determin
appropri
screen
criteria
geckler
et
al
compar
result
variou
criteria
expector
sputa
result
transtrach
aspir
studi
show
best
agreement
criterion
less
secslpf
agreement
sputa
sampl
tta
result
specimen
less
sec
compar
specimen
show
sec
total
specimen
examin
subsequ
report
gram
stain
sputum
transtrach
aspir
tta
specimen
patient
acut
pneumonia
interpret
laboratori
staff
hous
staff
predict
pathogen
grew
tta
cultur
case
base
sputum
gram
stain
case
base
gram
stain
tta
result
demonstr
good
correl
gramstain
result
expector
sputum
tta
also
enorm
variat
interpret
gram
stain
either
sourc
number
specimen
accept
cultur
cytolog
screen
depend
larg
extent
criteria
use
laboratori
show
specimen
reject
cultur
use
commonli
accept
criteria
laboratori
also
report
improv
qualiti
specimen
standard
impos
two
caveat
regard
use
criteria
cytolog
screen
appropri
studi
legionella
spp
acidfast
bacilli
specimen
obtain
use
hyperton
salin
induc
sputum
gener
provid
inadequ
specimen
high
concentr
sec
routin
cultur
expector
sputum
receiv
mix
review
analog
way
review
gram
stain
studi
shown
specimen
good
correl
reliabl
specimen
blood
cultur
transtrach
aspir
studi
shown
littl
valu
limit
impos
realiti
clinic
practic
patient
pneumonia
fail
produc
adequ
specimen
diagnost
studi
mani
patient
receiv
anteced
treatment
antimicrobi
agent
preclud
meaning
cultur
especi
recoveri
fragil
common
pathogen
pneumonia
h
influenza
anoth
major
problem
concern
adequ
implement
qualiti
assur
especi
time
resourc
microbiolog
studi
limit
mani
hospit
outsourc
servic
issu
import
compon
qualiti
control
includ
follow
cultur
perform
rapidli
collect
retain
room
temperatur
although
requir
disput
investig
standard
microbiolog
laboratori
plate
within
hour
retain
sputum
c
length
delay
hour
practic
prevent
overgrowth
contamin
minor
speci
cytolog
screen
done
conting
accept
cultur
although
specif
criteria
variabl
see
earlier
discuss
standard
laboratori
media
respiratori
secret
sheep
blood
agar
macconkey
agar
chocol
agar
chocol
agar
gener
incub
carbon
dioxid
facilit
recoveri
h
influenza
legionella
spp
bordetella
pertussi
requir
special
media
potenti
pathogen
identifi
report
includ
pneumonia
aureu
streptococcu
pyogen
h
influenza
enterobacteriacea
moraxella
catarrhali
neisseria
meningitidi
report
yeast
cryptococcu
neoforman
concentr
bacteria
import
often
neglect
aspect
interpret
facet
analysi
formal
quantit
cultur
bronchoscopi
specimen
appli
conceptu
expector
sputum
cultur
true
pathogen
recov
moder
heavi
growth
mean
recoveri
occur
third
fourth
streak
use
standard
plate
procedur
correl
gramstain
result
laboratori
protocol
gramstain
direct
mean
extent
microbiolog
studi
determin
gramstain
result
sampl
error
fleck
pick
introduc
error
qualiti
control
within
laboratori
often
requir
advocaci
select
group
infecti
diseas
specialist
pulmonari
physician
infectioncontrol
specialist
pharmaci
committe
group
need
commun
regular
basi
establish
method
achiev
optim
result
advoc
adequ
resourc
current
yield
like
pathogen
report
studi
hospit
patient
pneumonia
like
concert
effort
improv
yield
requir
campaign
promot
need
patient
cap
rare
requir
invas
diagnost
techniqu
sometim
techniqu
done
except
case
diagnost
test
done
anoth
indic
microbiolog
studi
may
secondari
goal
experi
techniqu
enrich
total
knowledg
etiolog
agent
microbiolog
principl
follow
section
brief
review
techniqu
transtrach
aspir
origin
describ
pecora
yegian
method
obtain
specimen
lower
airway
free
contamin
upper
airway
procedur
perform
use
needl
intermediates
intracath
insert
cricoid
membran
cathet
pass
full
extent
needl
withdrawn
aspir
perform
syring
salin
may
instil
facilit
specimen
collect
step
infrequ
necessari
avoid
possibl
dilut
specimen
make
semiquantit
cultur
result
less
meaning
drop
secret
necessari
microbiolog
studi
procedur
use
extens
sever
investig
fell
disfavor
result
patient
nonaccept
concern
complic
argument
unnecessari
optim
care
given
adequaci
empir
antibiot
treatment
patient
major
complic
bleed
site
needl
insert
cough
paroxysm
could
compromis
air
exchang
cathet
place
lower
airway
profound
irrit
foreign
bodi
trachea
unaccept
facet
procedur
patient
seriou
complic
rare
oper
skill
patient
contraind
numer
report
result
techniqu
uniformli
favor
term
diagnost
result
provid
specimen
obtain
antibiot
treatment
use
techniqu
healthi
medic
student
establish
microbiolog
principl
justifi
approach
show
tracheobronchi
tree
normal
steril
larynx
healthi
person
studi
patient
uniformli
favor
term
diagnost
yield
largest
publish
report
includ
patient
satisfi
criteria
probabl
bacteri
pneumonia
base
fever
pulmonari
infiltr
chest
radiograph
clinic
respons
antibiot
treatment
patient
like
pulmonari
pathogen
recov
transtrach
aspir
tta
patient
falseneg
cultur
receiv
previou
antibiot
treatment
major
caus
falseposit
cultur
presum
presenc
chronic
lung
diseas
colon
lower
airway
techniqu
use
studi
pulmonari
infect
involv
anaerob
bacteria
meaning
cultur
anaerob
requir
uncontamin
specimen
even
patient
chronic
lung
diseas
anaerob
lower
airway
occasion
except
patient
bronchiectasi
bronchoscopi
prove
valuabl
detect
etiolog
agent
pulmonari
infect
particularli
patient
pneumocysti
carinii
infect
patient
mycobacterium
tuberculosi
infect
expector
sputum
sampl
detect
convent
bacteria
techniqu
better
expector
sputum
inevit
contamin
inner
channel
passag
airway
altern
method
use
extens
better
result
employ
quantit
cultur
bal
specimen
specimen
collect
doubl
lumen
brush
cathet
techniqu
first
describ
wimberli
et
al
becom
popular
though
controversi
method
studi
patient
nosocomi
pneumonia
icu
particularli
patient
ventilatorassoci
pneumonia
occasion
use
patient
cap
enigmat
pneumonia
requir
technic
expertis
need
collect
specimen
institut
antibiot
therapi
effect
empir
antibiot
given
rapidli
gener
preclud
practic
use
patient
acut
pulmonari
infect
among
patient
cap
bronchoscopi
commonli
use
patient
chronic
enigmat
pulmonari
infect
empir
antibiot
difficult
select
rapid
institut
treatment
mandat
clinic
present
use
quantit
cultur
base
principl
pulmonari
infect
bacteria
almost
alway
associ
bacteria
concentr
exceed
ml
concentr
consid
signific
brush
cathet
usual
ml
bal
usual
ml
concentr
reflect
dilut
effect
procedur
process
transthorac
needl
aspir
permit
collect
uncontamin
specimen
directli
pulmonari
parenchym
cytolog
microbiolog
analysi
procedur
initi
introduc
done
ct
guidanc
permit
sampl
small
lesion
usual
perform
thinwal
spinal
needl
extens
report
experi
techniqu
detect
convent
bacteria
year
ago
techniqu
rare
perform
except
patient
usual
lesion
present
time
extens
experi
earlier
period
report
bullowa
examin
lung
aspir
patient
suspect
pneumococc
pneumonia
posit
result
obtain
patient
diagnost
yield
among
patient
bacterem
pneumonia
yield
pneumonia
presum
explan
falseneg
result
improp
placement
needl
nonviabl
organ
patient
review
publish
report
techniqu
show
yield
microbi
pathogen
rang
rate
falseposit
result
virtual
nil
pneumonia
alway
rank
first
among
identifi
pathogen
patient
cap
decreas
yield
sequenti
studi
prepenicillin
era
pneumonia
account
pneumonia
lobar
pneumonia
continu
reduct
yield
pneumococcu
studi
past
decad
gener
show
organ
account
case
declin
often
regard
artifact
microbiolog
reflect
diminish
qualiti
interest
laboratori
diagnosi
result
nondetect
bacteri
pathogen
case
metaanalysi
report
englishlanguag
literatur
cap
show
approxim
patient
defin
bacteri
pathogen
pneumonia
account
case
categori
case
lethal
outcom
pneumonia
account
approxim
patient
bacterem
cap
much
higher
frequenc
case
aggress
diagnost
method
transtrach
aspir
use
british
thorac
societi
pneumonia
research
committe
review
case
cap
identifi
pathogen
conclud
case
probabl
caus
pneumonia
establish
diagnosi
pneumococc
pneumonia
requir
recoveri
organ
uncontamin
specimen
sourc
blood
pleural
fluid
transtrach
aspir
transthorac
needl
aspir
note
organ
account
bacterem
cap
case
case
account
hospit
patient
cap
patient
empyema
bacteremia
undergo
invas
diagnost
test
diagnosi
pursu
gram
stain
cultur
expector
sputum
note
gram
stain
subject
substanti
subject
variat
depend
qualiti
specimen
expertis
observ
cultur
problemat
produc
falseposit
falseneg
result
falseposit
result
occur
result
adult
patient
colon
pneumonia
pharynx
falseneg
result
occur
imperfect
sputum
bacteriolog
multipl
studi
show
diagnost
yield
less
patient
bacterem
pneumococc
pneumonia
special
techniqu
improv
yield
falseneg
result
includ
stain
expector
sputum
special
method
detect
pneumococc
polysaccharid
includ
quellung
test
latex
agglutin
counterimmunoelectrophoresi
urin
respiratori
secret
potenti
import
develop
commerci
avail
urinari
antigen
test
use
rapid
immunochromatograph
assay
one
prospect
control
trial
show
posit
result
adult
pneumococc
bacteremia
adult
septicemia
caus
microb
studi
show
sensit
specif
least
good
gram
stain
cultur
advantag
rapid
result
diagnost
use
antibiot
treatment
specimen
avail
patient
expector
sputum
disadvantag
sensit
less
children
higher
courag
rate
pneumonia
sensit
may
less
adult
nonbacterem
pneumonia
pathogen
sensit
test
estim
frequenc
c
pneumonia
respons
hospit
case
cap
rang
organ
found
often
question
regard
relev
inadequaci
test
frequenc
copathogen
seem
dictat
cours
detect
method
includ
cultur
c
pneumonia
pcr
serolog
cultur
requir
use
cell
cultur
gener
avail
except
research
laboratori
pcr
techniqu
may
use
reagent
clear
food
drug
administr
fda
poorli
standard
frequent
use
assay
microimmunofluorescen
mif
assay
detect
igm
fourfold
increas
igg
titer
center
diseas
control
prevent
review
diagnost
method
conclud
pcr
assay
adequ
home
grown
mean
commerci
avail
regard
mif
assay
diagnost
criteria
igm
titer
exceed
fourfold
increas
igg
titer
report
caus
cap
oblig
criteria
reliabl
incid
data
avail
studi
shown
poor
interobserv
consist
interpret
mif
assay
interpret
two
expert
specimen
patient
show
poor
correl
jvalu
dichotom
titer
versu
conclus
goldstandard
method
cultur
routin
avail
laboratori
standard
mif
assay
poorli
standard
promis
test
pcr
laboratori
test
detect
pneumonia
infect
includ
cultur
serolog
pcr
serolog
igm
igg
becom
elev
mani
case
respons
often
delay
use
test
earli
detect
limit
use
also
limit
reproduc
test
author
consid
pcr
promis
substanti
variat
specimen
collect
sampl
prepar
amplif
procedur
reagent
reagent
pcr
detect
approv
fda
one
report
patient
atyp
pathogen
includ
patient
pneumonia
infect
atyp
pathogen
occur
frequent
patient
typic
pneumonia
atyp
pneumonia
determin
clinic
featur
observ
emphas
difficulti
establish
diagnosi
pneumonia
infect
basi
clinic
featur
laboratori
studi
legionella
spp
implic
cap
case
may
caus
epidem
includ
nosocomi
epidem
result
substanti
mortal
rate
even
treat
appropri
antibiot
laboratori
method
detect
includ
cultur
serolog
direct
immunofluoresc
antibodi
stain
urinari
antigen
assay
pcr
rel
merit
test
outlin
tabl
confound
issu
noncultur
assay
legionella
spp
total
serogroup
l
pneumophila
caus
case
serogroup
account
within
speci
guidelin
infecti
diseas
societi
america
recommend
two
test
cultur
detect
speci
technic
demand
ie
larg
number
falseneg
result
mani
laboratori
urinari
antigen
assay
easi
perform
provid
rapid
result
main
limit
urinari
antigen
assay
detect
l
pneumophila
serogroup
organ
account
sporad
case
legionnair
diseas
diagnost
use
assay
summar
report
helbig
et
al
among
patient
cultureproven
legionella
spp
infect
urinari
antigen
assay
sensit
exceed
patient
communityacquir
hotelassoci
legionnair
diseas
patient
nosocomi
diseas
tabl
infer
l
pneumophila
may
occur
less
frequent
hospitalacquir
case
import
implic
test
secret
fda
approv
pcr
method
detect
l
pneumophilia
includ
serotyp
use
respiratori
tract
secret
anaerob
bacteria
domin
oropharyng
flora
rel
common
caus
aspir
pneumonia
lung
abscess
major
mechan
establish
diagnosi
requir
specimen
devoid
upper
airway
flora
transtrach
aspir
pleural
fluid
transthorac
needl
aspir
uncontamin
specimen
metastat
site
studi
anaerob
pulmonari
infect
done
tta
procedur
longer
common
anaerob
lung
infect
almost
never
prove
unless
empyema
present
limit
experi
bronchoscopi
specimen
use
bal
protect
brush
cathet
total
experi
spars
limit
laboratori
special
skill
necessari
success
cultur
anaerob
anaerob
infect
lung
rare
confirm
bacteriolog
studi
absenc
empyema
clinic
suspicion
infect
often
help
howev
putrid
sputum
empyema
fluid
consid
diagnost
anaerob
infect
aspir
pneumonia
typic
predispos
condit
usual
caus
anaerob
necrosi
tissu
lung
abscess
bronchoplur
fistula
strongli
suggest
caus
three
categori
agent
caus
pneumonia
bacillu
anthraci
franciscella
tularensi
yersinia
pesti
experi
inhal
anthrax
come
epidem
attribut
bioterror
patient
develop
diseas
event
case
inhal
anthrax
occur
unit
state
sinc
diagnosi
inhal
anthrax
made
basi
clinic
laboratori
observ
includ
sever
clinic
clue
distinguish
diseas
common
form
cap
laboratori
test
particularli
suggest
wide
mediastinum
chest
radiograph
hyperdens
mediastin
node
chest
ct
scan
bloodi
pleural
effus
best
method
confirm
diagnosi
blood
cultur
posit
eight
patient
specimen
collect
antibiot
therapi
cultur
posit
within
hour
tularemia
put
agent
may
cultur
blood
sputum
pharyng
exud
difficulti
use
special
media
contain
cystein
sulfahydroxyl
compound
thioglycol
broth
charcoalyeast
agar
organ
hazard
laboratori
personnel
cultur
biolog
safeti
level
laboratori
diagnost
method
includ
pcr
enzym
immunoassay
eia
immunoblot
pulsedfield
gel
electrophoresi
test
gener
avail
research
public
health
laboratori
testi
cultur
sputum
blood
gram
stain
typic
appear
safetypinshap
bipolarstain
gramneg
coccobacillu
diagnosi
suspect
specimen
divid
incub
c
rapid
growth
c
identif
capsular
antigen
abbrevi
afb
acidfast
stain
ag
antigen
bronch
bronchoscopi
aspir
bal
cf
complement
fixat
eia
enzym
immunoassay
fa
fluoresc
antibodi
ifa
immunofluoresc
assay
la
latex
agglutin
mif
microimmunofluoresc
assay
np
nasopharyng
swab
sg
serogroup
entri
parenthes
usual
avail
diagnost
test
detect
etiolog
agent
pneumonia
neither
recommend
done
outpati
cap
tabl
patient
clear
diagnosi
seem
well
empir
antibiot
treatment
often
cost
less
diagnost
test
hospit
patient
pretreat
blood
cultur
expector
sputum
gram
stain
cultur
done
test
legionella
spp
appropri
hospit
patient
especi
serious
ill
new
test
merit
use
select
patient
urinari
antigen
assay
pneumonia
pcr
test
l
pneumophila
anticip
develop
near
futur
pcr
test
detect
c
pneumonia
pneumonia
